The latest on Feldan products and innovations. Check our blog regularly to stay informed.

Feldan at Biotech Showcase and RESI meeting

Feldan will be attending Biotech Showcase (Jan. 11th-13th, 2016) and RESI meetings (Jan. 12th) in San Francisco, CA next week. Come listen to our CEO, Francois-Thomas Michaud, presenting the company on Jan. 11th at 3:45PM in the Hearst Room. We will be happy to meet you there. About Biotech Showcase Biotech Showcase™ is an investor […]

Cas9 protein: the discovery that shook science

To follow up on our post, A beginner’s guide to genome editing, here is more information on the cas9 protein. For years, scientists have tried to modify DNA to influence the intrinsic characteristics of cells. Among other examples, some have used homologous recombination to knock-in genes, while others have indirectly altered the mRNA expression via […]

Cell therapy, together with genome editing, will give a chance to leukaemia patients

A recent news show, once again, that cell therapy can become tomorrow treatment for many diseases. A research team from Great Ormond Street Hospital and UCL Institute of Child Health’s (ICH) developed a cell therapy treatment that saved a young baby whose life was hanging by a thread. This treatment consisted in adding new genes […]

A beginner’s guide to genome editing

Every now and then, a new method is discovered and redefines the way that scientists are conducting experiments in the laboratory. In the last years, the techniques associated to genome editing has taken molecular biology by storm, and as scientists it is why it is crucial to be aware of the discoveries that led to […]

Interview of Francois-Thomas Michaud on Canal Argent

If you did not get a chance to see the interview of Francois-Thomas Michaud with Francois Gilbert on Canal Argent this past Friday October 2nd 2015, you can watch it here.

Feldan is proud to announce that it has secured an investment of over $1.7 million from angel investors to support continued growth

Angel investors, the Anges Québec Capital fund, and other partners complete the fourth round of financing for the Quebec City–based SME Quebec City, October 2, 2015 – Members of Anges Québec, the Anges Québec Capital fund, and other angel investors have given Feldan a $1,723,000 cash injection during a fourth round of financing. The Quebec […]

Feldan’s highlights of the Cold Spring Harbor meeting on the CRISPR/Cas9 system

Feldan would like to thank the organizers of the first Cold Spring Harbor meeting about genome engineering and CRISPR/Cas9 system. We have been fortunate to witness scientific history in the making at the famous New York campus last week (September 24-27). The meeting organized by Dr Jennifer Doudna, (University of California, Berkeley/HHMI), Dr Maria Jasin […]

Feldan is attending Stem Cell on the Mesa in La Jolla, October 7th!

Feldan participated at the Stem Cell on the Mesa conference last year and we had such a great outcome that we are returning again this year. If you are attending as well and would like to learn more about Feldan Shuttle Technology or if you are interested in our Clinical grade cytokines, please let us […]

The HMR is once again making a difference for Stem Cell patients

One of our partners, the Maisonneuve-Rosemont Hospital (HMR), affiliated to CellCAN, has raised 48,000$ during the fourth edition of the biking challenge “Roulons pour la thérapie cellulaire”. Over 60 bikers participated in the event as part of the Vélo Québec Eastern Townships challenge to raise money for Stem Cell research. Thank you for this great […]

Top 7 upcoming North-American Conferences to attend in Cell Therapy

The fiscal year is almost done and we are currently making projections regarding our traveling budget. Conferences are a MUST for us as a growing company to increase our knowledge of the Cell Therapy Industry. We have found many conferences around the world that sounds very interesting and have already targeted seven North American conferences: […]